Search company, investor...

Stage

Other Investors | Alive

Total Raised

$250K

About CardioMetrix

CardioMetrix is a medical device company developing implantable technologies to assist physicians in managing patients suffering from congestive heart failure (CHF).

Headquarters Location

11805 North Creek Pkwy S # 101

Bellevue, Washington, 98011,

United States

Loading...

Loading...

CardioMetrix Patents

CardioMetrix has filed 2 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/3/2014

10/4/2016

Mass spectrometry, Molecular biology, Ion source, Fluid dynamics, Colloidal chemistry

Grant

Application Date

1/3/2014

Grant Date

10/4/2016

Title

Related Topics

Mass spectrometry, Molecular biology, Ion source, Fluid dynamics, Colloidal chemistry

Status

Grant

CardioMetrix Frequently Asked Questions (FAQ)

  • Where is CardioMetrix's headquarters?

    CardioMetrix's headquarters is located at 11805 North Creek Pkwy S # 101, Bellevue.

  • What is CardioMetrix's latest funding round?

    CardioMetrix's latest funding round is Other Investors.

  • How much did CardioMetrix raise?

    CardioMetrix raised a total of $250K.

  • Who are the investors of CardioMetrix?

    Investors of CardioMetrix include Alliance of Angels and Affinity Capital Management.

  • Who are CardioMetrix's competitors?

    Competitors of CardioMetrix include Avertix, Ancora Heart, Respicardia, Mitralign, CardioKinetix and 7 more.

Loading...

Compare CardioMetrix to Competitors

C
Cardiac Power

Cardiac Power is a non-blood-contacting left ventricular assist device for the treatment of congestive heart failure

C
CardioKinetix

CardioKinetix develops a percutaneous treatment for patients with left ventricular dilation after an anterior myocardial infarction (MI). The implantable device, called the PARACHUTE is a partitioning membrane deployed within the compromised ventricle. The PARACHUTE partitions the damaged muscle, isolating the non-functional muscle segment from the functional segment, and decreases the overall volume. Options for patients whose ventricle has enlarged are limited, with most on medical therapy and/or a cardiac resynchronization device that only benefits heart failure patients with a specific EKG pattern.

NeoChord Logo
NeoChord

NeoChord is a medical technology company engaged in the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. The company's flagship product, the NeoChord Artificial Chordae Delivery System, is a beating heart procedure, echo-guided treatment for patients with mitral valve regurgitation, and is proven to resolve and restore normal mitral valve function. It was formerly known as mValve. The company was founded in 2007 and is based in St. Louis Park, Minnesota.

B
Bio Control Medical

Bio Control Medical offers implantable devices for the treatment of incontinence and congestive heart failure.

Cardiac Dimensions Logo
Cardiac Dimensions

Cardiac Dimensions is a company focused on improving the treatment of heart failure in the healthcare sector. The company offers a non-surgical device, designed to treat patients with mitral valve insufficiency, which works with the natural structure and function of the heart to treat the condition and related symptoms. The company primarily sells to the healthcare industry. It was founded in 2000 and is based in Kirkland, Washington.

A
Arbor Surgical Technologies

Arbor Surgical Technologies, Inc. with facilities located in Irvine and Portola Valley, CA (USA), is a privately held cardiovascular medical device company focused on the heart valve replacement market. Founded in 2002 by Dr. Thomas J. Fogarty and noted heart valve designer, Ernie Lane, Arbor is developing multiple technologies that have the potential to deliver significant clinical benefit to patients worldwide. Arbor intends to develop and commercialize its core technologies in varying combinations, giving the company the opportunity to create a broad portfolio of product offerings. Currently in clinical trials, Arbor is developing a tissue heart valve family of products designed for improved performance over existing valves and compatible implantation tools that simplify and speed valve replacement surgery. Arbor Surgical Technologies mission is to simplify cardiac valve surgery through the innovative development of a less invasive, unique implantation system and valves with superior performance and durability. Partnering with physicians, we will improve patient recovery by less invasive techniques and reduced surgery time. Ethical behavior with employees, surgeons, patients and suppliers is the keystone to our success.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.